April 29, 2024 16:39 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Congress' Indore Lok Sabha candidate Akshay Bam joins BJP just days ahead of elections | Delhi Police registers case over doctored video of Amit Shah advocating abolition of reservation | After delaying India trip, Elon Musk visits China, meets Premier Li Qiang | 'Not joining any other party': Arvinder Singh Lovely after resigning as Delhi Congress chief | Bus carrying 36 people erupts in flames in Mumbai-Pune Expressway, all passengers safe
Dr Reddy's acquires rights to an investigational anti-cancer agent

Dr Reddy's acquires rights to an investigational anti-cancer agent

Hyderabad, Mar 31 (IBNS) Dr Reddy's Laboratories, an integrated pharmaceutical company, announced on Thursday that it has entered into a licensing agreement with Eisai Company Limited of Japan, by which Dr Reddy's will be granted exclusive worldwide development and commercialization rights (excluding Japan and Asia) for Eisai's investigational anticancer agent E7777.